Ventrus sets IPO range

Ventrus Biosciences Inc. (New York, N.Y.) amended its IPO and now hopes to sell 2.8 million shares at $6-$7. A $6.50 price would raise $18.2 million and value the company at $41.5 million. Rodman and ...